Featured Articles
Featured
In their latest newsletter, the National Keratoconus Foundation (NKCF), highlights Epion Therapeutics’ Phase 3 trials of the EpiSmart Epithelium-On Cross-Linking System.
Keratoconus is a progressive disease with significant visual and quality of life implications. CXL can slow progression of the disease in a very high proportion of patients. Safe and effective CXL treatment predicates the importance of early disease diagnosis.
Published in Contact Lens Spectrum
Jennifer Harthan, OD, FAAO, FSLS, shared the importance of early diagnostics and pediatric screening of keratoconus at the IKA 2024 Symposium.
Ophthalmology Times
The number of keratoconus treatment options is growing, with new techniques and devices in development.
Published in Review of Ophthalmology
Leaders of several ophthalmic companies provide updates on their pipeline and new products in this special edition of EyewireTV.
A look at what’s coming to cross-linking, both in and out of the FDA pipeline.
Published in Review of Ophthalmology